位置:首页 > 蛋白库 > LMNB2_MOUSE
LMNB2_MOUSE
ID   LMNB2_MOUSE             Reviewed;         596 AA.
AC   P21619; P48680; Q8CGB1;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   03-AUG-2022, entry version 187.
DE   RecName: Full=Lamin-B2;
DE   Flags: Precursor;
GN   Name=Lmnb2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B2).
RX   PubMed=2102682; DOI=10.1007/bf01726689;
RA   Hoeger T.H., Zatloukal K., Waizenegger I., Krohne G.;
RT   "Characterization of a second highly conserved B-type lamin present in
RT   cells previously thought to contain only a single B-type lamin.";
RL   Chromosoma 99:379-390(1990).
RN   [2]
RP   ERRATUM OF PUBMED:2102682.
RX   PubMed=2102440; DOI=10.1007/bf00337604;
RA   Hoeger T.H., Zatloukal K., Waizenegger I., Krohne G.;
RL   Chromosoma 100:67-69(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B3).
RX   PubMed=8094052; DOI=10.1002/j.1460-2075.1993.tb05635.x;
RA   Furukawa K., Hotta Y.;
RT   "cDNA cloning of a germ cell specific lamin B3 from mouse spermatocytes and
RT   analysis of its function by ectopic expression in somatic cells.";
RL   EMBO J. 12:97-106(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B2).
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 165-172; 254-262 AND 482-491.
RX   PubMed=1939065; DOI=10.1016/s0021-9258(18)54886-9;
RA   Kasahara K., Chida K., Tsunenaga M., Kohno Y., Ikuta T., Kuroki T.;
RT   "Identification of lamin B2 as a substrate of protein kinase C in BALB/MK-2
RT   mouse keratinocytes.";
RL   J. Biol. Chem. 266:20018-20023(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 182-206; 234-286; 290-319; 364-401 AND 470-496.
RX   PubMed=2311764; DOI=10.1016/0014-5793(90)80592-7;
RA   Weber K., Plessmann U., Traub P.;
RT   "Protein chemical analysis of purified murine lamin B identifies two
RT   distinct polypeptides B1 and B2.";
RL   FEBS Lett. 261:361-364(1990).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [8]
RP   INTERACTION WITH TMEM43.
RX   PubMed=18230648; DOI=10.1242/jcs.019281;
RA   Bengtsson L., Otto H.;
RT   "LUMA interacts with emerin and influences its distribution at the inner
RT   nuclear membrane.";
RL   J. Cell Sci. 121:536-548(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-413, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer
CC       on the nucleoplasmic side of the inner nuclear membrane, which is
CC       thought to provide a framework for the nuclear envelope and may also
CC       interact with chromatin. {ECO:0000250|UniProtKB:Q03252}.
CC   -!- SUBUNIT: Interacts with TMEM43. {ECO:0000269|PubMed:18230648}.
CC   -!- SUBCELLULAR LOCATION: Nucleus lamina {ECO:0000250|UniProtKB:Q03252}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B2;
CC         IsoId=P21619-1; Sequence=Displayed;
CC       Name=B3;
CC         IsoId=P21619-2, P48680-1;
CC         Sequence=VSP_017070;
CC   -!- TISSUE SPECIFICITY: Isoform B3 is germ cell specific.
CC   -!- PTM: B-type lamins undergo a series of modifications, such as
CC       farnesylation and phosphorylation. Increased phosphorylation of the
CC       lamins occurs before envelope disintegration and probably plays a role
CC       in regulating lamin associations.
CC   -!- MISCELLANEOUS: The structural integrity of the lamina is strictly
CC       controlled by the cell cycle, as seen by the disintegration and
CC       formation of the nuclear envelope in prophase and telophase,
CC       respectively.
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH42430.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH51985.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X54098; CAA38032.1; -; mRNA.
DR   EMBL; D13455; BAA02708.1; -; mRNA.
DR   EMBL; BC042430; AAH42430.1; ALT_INIT; mRNA.
DR   EMBL; BC051985; AAH51985.1; ALT_INIT; mRNA.
DR   CCDS; CCDS83733.1; -. [P21619-2]
DR   PIR; B48315; B48315.
DR   PIR; S28419; S28419.
DR   RefSeq; NP_001334069.1; NM_001347140.1. [P21619-2]
DR   RefSeq; NP_034852.2; NM_010722.5.
DR   AlphaFoldDB; P21619; -.
DR   SMR; P21619; -.
DR   BioGRID; 201178; 11.
DR   IntAct; P21619; 4.
DR   MINT; P21619; -.
DR   STRING; 10090.ENSMUSP00000057291; -.
DR   iPTMnet; P21619; -.
DR   PhosphoSitePlus; P21619; -.
DR   EPD; P21619; -.
DR   jPOST; P21619; -.
DR   MaxQB; P21619; -.
DR   PaxDb; P21619; -.
DR   PeptideAtlas; P21619; -.
DR   PRIDE; P21619; -.
DR   ProteomicsDB; 286221; -. [P21619-1]
DR   ProteomicsDB; 286222; -. [P21619-2]
DR   Antibodypedia; 10783; 364 antibodies from 37 providers.
DR   DNASU; 16907; -.
DR   Ensembl; ENSMUST00000105332; ENSMUSP00000100969; ENSMUSG00000062075. [P21619-2]
DR   Ensembl; ENSMUST00000179022; ENSMUSP00000136524; ENSMUSG00000062075. [P21619-1]
DR   GeneID; 16907; -.
DR   KEGG; mmu:16907; -.
DR   UCSC; uc007gfk.1; mouse. [P21619-1]
DR   CTD; 84823; -.
DR   MGI; MGI:96796; Lmnb2.
DR   VEuPathDB; HostDB:ENSMUSG00000062075; -.
DR   eggNOG; KOG0977; Eukaryota.
DR   GeneTree; ENSGT00940000160274; -.
DR   HOGENOM; CLU_012560_9_2_1; -.
DR   InParanoid; P21619; -.
DR   OrthoDB; 701388at2759; -.
DR   PhylomeDB; P21619; -.
DR   TreeFam; TF101181; -.
DR   BioGRID-ORCS; 16907; 1 hit in 73 CRISPR screens.
DR   ChiTaRS; Lmnb2; mouse.
DR   PRO; PR:P21619; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; P21619; protein.
DR   Bgee; ENSMUSG00000062075; Expressed in spermatid and 170 other tissues.
DR   ExpressionAtlas; P21619; baseline and differential.
DR   Genevisible; P21619; MM.
DR   GO; GO:0005638; C:lamin filament; IDA:MGI.
DR   GO; GO:0005635; C:nuclear envelope; IDA:MGI.
DR   GO; GO:0005652; C:nuclear lamina; IBA:GO_Central.
DR   GO; GO:0031965; C:nuclear membrane; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IBA:GO_Central.
DR   GO; GO:0031507; P:heterochromatin assembly; IBA:GO_Central.
DR   GO; GO:0006998; P:nuclear envelope organization; IBA:GO_Central.
DR   GO; GO:0007097; P:nuclear migration; IBA:GO_Central.
DR   GO; GO:0051664; P:nuclear pore localization; IBA:GO_Central.
DR   GO; GO:0090435; P:protein localization to nuclear envelope; IBA:GO_Central.
DR   Gene3D; 2.60.40.1260; -; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR001322; Lamin_tail_dom.
DR   InterPro; IPR036415; Lamin_tail_dom_sf.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF00932; LTD; 1.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF74853; SSF74853; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
DR   PROSITE; PS51841; LTD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coiled coil; Direct protein sequencing;
KW   Intermediate filament; Isopeptide bond; Lipoprotein; Methylation; Nucleus;
KW   Phosphoprotein; Prenylation; Reference proteome; Ubl conjugation.
FT   CHAIN           1..593
FT                   /note="Lamin-B2"
FT                   /id="PRO_0000063821"
FT   PROPEP          594..596
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000403471"
FT   DOMAIN          24..380
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   DOMAIN          438..559
FT                   /note="LTD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01187"
FT   REGION          1..26
FT                   /note="Head"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          27..61
FT                   /note="Coil 1A"
FT   REGION          62..73
FT                   /note="Linker 1"
FT   REGION          74..207
FT                   /note="Coil 1B"
FT   REGION          208..234
FT                   /note="Linker 2"
FT   REGION          235..378
FT                   /note="Coil 2"
FT   REGION          376..440
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          379..596
FT                   /note="Tail"
FT   REGION          552..596
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           415..420
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        384..408
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        425..440
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         12
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         59
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         400
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         402
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         413
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   MOD_RES         593
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250"
FT   LIPID           593
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        59
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   CROSSLNK        173
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   CROSSLNK        233
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   CROSSLNK        465
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q03252"
FT   VAR_SEQ         1..206
FT                   /note="MASLPPHAGPATPLSPTRLSRLQEKEELRELNDRLAHYIDRVRALELENDRL
FT                   LLRISEKEEVTTREVSGIKTLYESELADARRVLDETARERARLQIEIGKVQAELEEARK
FT                   SAKKREGELTVAQGRVKDLESLFHRSEAELATALSDKQGLETEVAELRAQLAKAEDGHA
FT                   VAKKQLEKETLMRVDLENRCQSLQEELAFSKSVFEE -> MGESESMRGTGEGCGRDCP
FT                   EAARPLMETVEGALPELRGRPLREYVKRRPRGLGKTPVEDPVKSEGAVGYPRTWNNHLR
FT                   VPTREQ (in isoform B3)"
FT                   /evidence="ECO:0000303|PubMed:8094052"
FT                   /id="VSP_017070"
FT   CONFLICT        148..149
FT                   /note="KQ -> NE (in Ref. 1; CAA38032)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        314
FT                   /note="H -> R (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        321
FT                   /note="A -> R (in Ref. 1; CAA38032)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="A -> R (in Ref. 1; CAA38032)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403
FT                   /note="Missing (in Ref. 1; CAA38032)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        412..413
FT                   /note="GR -> RG (in Ref. 1; CAA38032)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421..422
FT                   /note="Missing (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="Missing (in Ref. 1; CAA38032)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   596 AA;  67318 MW;  4FEF5A76FFDF2D96 CRC64;
     MASLPPHAGP ATPLSPTRLS RLQEKEELRE LNDRLAHYID RVRALELEND RLLLRISEKE
     EVTTREVSGI KTLYESELAD ARRVLDETAR ERARLQIEIG KVQAELEEAR KSAKKREGEL
     TVAQGRVKDL ESLFHRSEAE LATALSDKQG LETEVAELRA QLAKAEDGHA VAKKQLEKET
     LMRVDLENRC QSLQEELAFS KSVFEEEVRE TRRRHERRLV EVDSSRQQEY DFKMAQALED
     LRSQHDEQVR LYRVELEQTY QAKLDNAKLL SDQNDKAAHA AREELKEARM RVESLSYQLL
     GLQKQASAAE NHIHELEEAL AGERDKFRKM LDAKEQEMTE VRDAMQQQLA EYQELLDIKL
     ALDMEISAYR KLLEGEEERL KLSPSPSSRI TISRATSSSS SSSGVGMSVG QGRGKRRRLE
     TEDTSGSPSR ASRVSSGSRL AQQTVATGVV NIDEVDPEGR FVRLKNSSDK DQSLGNWRIK
     RQVLEGEDIA YKFTPKYVLR AGQTVTVWAA GAGATHSPPS TLVWKSQTNW GPGESFRTAL
     VSADGEEVAV KAAKHSSVQG RENGEEEEEE EAEFGEEDLF HQQGDPRTTS RGCRLM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024